NAMPT and neoplasm: However, in other experiments, the in vivo antitumor effects of the NAMPT inhibitors, GNE-617 and GNE-618, were found to be abrogated by NA supplementation even in the xenografts of NAPRT-deficient cell lines and patient-derived xenograft tumor models [190].